Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Synergistic Effects Of A Combined Salbutamol-Nitroprusside Regimen In Acute Myocardial Infarction And Severe Left Ventricular Failure

Michael B. Fowler, Adam D. Timmis and Douglas A. Chamberlain
The British Medical Journal
Vol. 280, No. 6212 (Feb. 16, 1980), pp. 435-437
Published by: BMJ
Stable URL: http://www.jstor.org/stable/25438876
Page Count: 3
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Synergistic Effects Of A Combined Salbutamol-Nitroprusside Regimen In Acute Myocardial Infarction And Severe Left Ventricular Failure
Preview not available

Abstract

The haemodynamic effects of a simultaneous infusion of salbutamol and nitroprusside were measured in 20 patients with acute myocardial infarction and severe left ventricular failure. Six patients also had clinical manifestations of cardiogenic shock. Ten patients received salbutamol first with the subsequent addition of nitroprusside; in the other 10 patients nitroprusside was infused first. Salbutamol was infused at a constant rate of 20 μg/min in all patients, while the dose of nitroprusside, which averaged 51·25 μg/min, was adjusted to reduce left ventricular filling pressure (measured as pulmonary artery end-diastolic pressure) to approximately 15 mm Hg with reference to sternal angle. Cardiac index increased in all patients from a mean of 1·8 to 2·6 l/min/m² while pulmonary artery end-diastolic pressure fell significantly from 24 to 16 mm Hg. The adverse effects were small in most patients: heart rate did not increase significantly and systolic arterial pressure fell on average from 112 to 96 mm Hg. Ten of the 20 patients survived to leave hospital. Nitroprusside accounted for most of the fall in filling pressure irrespective of treatment sequence, whereas both drugs contributed to the augmented cardiac output. The haemodynamic benefits of this combined regimen were considerably greater than those achieved by either drug alone. Thus salbutamol and nitroprusside have synergistic effects which influence favourably the two principal manifestations of left ventricular dysfunction after extensive myocardial infarction.

Page Thumbnails

  • Thumbnail: Page 
435
    435
  • Thumbnail: Page 
436
    436
  • Thumbnail: Page 
437
    437